文献速递冠心病心力衰竭与心肌病

经皮机械循环支持与主动脉内球囊反搏在急性心肌梗死合并心源性休克中的比较

Percutaneous Mechanical Circulatory Support Versus Intra-Aortic Balloon Pump in Cardiogenic Shock After Acute Myocardial Infarction.
PubMed 文献 · J Am Coll Cardiol · 2016-10-31

该随机、前瞻性、开放标签、多中心探索性试验纳入48例急性心肌梗死合并严重心源性休克且需机械通气的患者,随机分为经皮机械循环支持(pMCS,Impella CP)组24例与主动脉内球囊反搏(IABP)组24例。30天全因死亡率两组相似(50%与46%;HR 0.96,95%CI 0.42–2.18,P=0.92),6个月死亡率均为50%(HR 1.04,95%CI 0.47–2.32,P=0.923)。

要点

  • 在需机械通气的AMI合并严重心源性休克患者中,pMCS较IABP未降低30天死亡率。
  • 30天死亡率pMCS组46%、IABP组50%,HR 0.96(95%CI 0.42–2.18,P=0.92)。
  • 6个月死亡率两组均为50%,HR 1.04(95%CI 0.47–2.32,P=0.923)。

核心结论

  • 在急性心肌梗死合并严重心源性休克且需机械通气的患者中,常规使用pMCS(Impella CP)与IABP相比未降低30天死亡率。

研究设计与样本

  • 随机、前瞻性、开放标签、多中心探索性试验,共纳入48例AMI合并严重心源性休克患者,pMCS组24例、IABP组24例。
  • 严重心源性休克定义为收缩压<90 mm Hg或需使用正性肌力或血管活性药物,且需要机械通气。

主要发现

  • 30天全因死亡率pMCS组46%、IABP组50%,HR 0.96(95%CI 0.42–2.18,P=0.92)。
  • 6个月死亡率pMCS组与IABP组均为50%,HR 1.04(95%CI 0.47–2.32,P=0.923)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Despite advances in treatment, mortality in acute myocardial infarction (AMI) complicated by cardiogenic shock (CS) remains high. Short-term mechanical circulatory support devices acutely improve hemodynamic conditions. OBJECTIVES: The aim of this study was to determine whether a new percutaneous mechanical circulatory support (pMCS) device (Impella CP, Abiomed, Danvers, Massachusetts) decreases 30-day mortality when compared with an intra-aortic balloon pump (IABP) in patients with severe shock complicating AMI. METHODS: In a randomized, prospective, open-label, multicenter trial, 48 patients with severe CS complicating AMI were assigned to pMCS (n = 24) or IABP (n = 24). Severe CS was defined as systolic blood pressure <90 mm Hg or the need for inotropic or vasoactive medication and the requirement for mechanical ventilation. The primary endpoint was 30-day all-cause mortality. RESULTS: At 30 days, mortality in patients treated with either IABP or pMCS was similar (50% and 46%, respectively; hazard ratio with pMCS: 0.96; 95% confidence interval: 0.42 to 2.18; p = 0.92). At 6 months, mortality rates for both pMCS and IABP were 50% (hazard ratio: 1.04; 95% confidence interval: 0.47 to 2.32; p = 0.923). CONCLUSIONS: In this explorative randomized controlled trial involving mechanically ventilated patients with CS after AMI, routine treatment with pMCS was not associated with reduced 30-day mortality compared with IABP. (IMPRESS in Severe Shock; NTR3450).

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Ouweneel DM, Eriksen E, Sjauw KD, et al. Percutaneous Mechanical Circulatory Support Versus Intra-Aortic Balloon Pump in Cardiogenic Shock After Acute Myocardial Infarction. J Am Coll Cardiol. 2016. PMID: 27810347. doi:10.1016/j.jacc.2016.10.022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。